CHELSEA SNYDER: Open Payments
NPI 1336719665 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 83 payments from 13 companies in 2025. Trend: 2023 $1,392 · 2024 $1,221 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $332 |
| Otsuka America Pharmaceutical, Inc. | 15 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $251 |
| ABBVIE INC. | 13 | $199 |
| Inspire Medical Systems, Inc. | 3 | $125 |
| Alkermes, Inc. | 5 | $110 |
| Janssen Pharmaceuticals, Inc | 3 | $90 |
| Corium, LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| TMS NeuroHealth Centers Inc. | 4 | $44 |
Products named: FANAPT, CAPLYTA, REXULTI, VRAYLAR, INSPIRE, ARISTADA, Azstarys, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
